Filter
292
Filtered Results: 292
Text search:
L.
Ferreira
Featured
Recommendations
39
New Publications
33
Language
Document type
No document type
84
Studies & Reports
80
Guidelines
73
Manuals
24
Strategic & Response Plan
15
Training Material
5
Fact sheets
5
Resource Platforms
4
Situation Updates
2
Countries / Regions
Brazil
37
Latin America and the Carribbean
19
Global
12
Paraguay
11
Western and Central Europe
9
Russia
9
Mozambique
8
Colombia
7
Eastern Europe
7
Ukraine
6
Kenya
4
Eastern Europe and Central Asia
4
Argentina
4
Africa
3
Germany
3
France
3
South Africa
3
Tajikistan
2
Sierra Leone
2
Kazakhstan
2
Kyrgyzstan
2
Middle East and North Africa
2
Portugal
2
Spain
2
Vietnam
2
Mexico
1
Turkey
1
China
1
Syria
1
Senegal
1
Guinea
1
Italy
1
Haiti
1
Venezuela
1
Tanzania
1
West and Central Africa
1
North America
1
Uruguay
1
United Kingdom
1
Southern Africa
1
Yemen
1
Ethiopia
1
Angola
1
Zambia
1
South Sudan
1
Liberia
1
Ecuador
1
India
1
Authors & Publishers
Publication Years
Category
Countries
107
Clinical Guidelines
24
Public Health
19
Women & Child Health
9
Key Resources
8
Capacity Building
5
Toolboxes
COVID-19
74
Mental Health
36
NTDs
27
TB
21
NCDs
21
HIV
15
Planetary Health
10
Disability
8
Caregiver
8
Zika
8
AMR
8
Malaria
5
Conflict
4
Global Health Education
4
Refugee
3
Natural Hazards
3
Ebola & Marburg
3
Rapid Response
2
Cholera
2
Pharmacy
2
Social Ethics
1
Health Financing Toolbox
1
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
English Analysis on Brazil about Health, Protection and Human Rights and Epidemic; published on 26 May 2021 by SSHAP
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
This revision covers the main non-communicable diseases in Mozambique as well as the National Strategic Plan's aim to create a positive environment to minimize or eliminate the exposure to risk factors and guarantee access to care.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
In recognition of the growing problem of antimicrobial resistance (AMR), its increasing threat to human, animal and plant health, and the need for a One Health approach to address this issue, the 39th Session of the Codex Alimentarius Commission (CAC) agreed it was important for the food safety comm...
Key populations brief.
BMJ Open Science 2021;5:e100202. doi:10.1136/
bmjos-2021-100202
Pharmaceuticals 2024, 17(6), 691; https://doi.org/10.3390/ph17060691
Informe sobre poblicationes clave.
